Lauren O. Bakaletz
Immunology and Microbiology · The Ohio State University
Publications
241
Citations
10,210
Est. group size
~3
Recurring co-author estimate
Active years
42
Publishing since 1985
Lauren O. Bakaletz's research focuses on bacterial biofilms, particularly those formed by nontypeable Haemophilus influenzae and related respiratory pathogens, and how these biofilms contribute to chronic and recurrent infections such as otitis media (middle ear infections) and chronic respiratory conditions like COPD and chronic rhinosinusitis. Her work investigates molecular mechanisms bacteria use to persist and evade treatment (such as phase variation, adhesins, and extracellular DNA-based biofilm matrices), and develops potential therapies including monoclonal antibodies and vaccine antigens aimed at disrupting biofilms and enhancing antibiotic effectiveness.
Publication output has gradually declined from about 9-12 papers per year in 2017-2020 to roughly 5 per year on average over the last five years, though a rebound occurred in 2025.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- A humanized monoclonal antibody potentiates killing of Pseudomonas aeruginosa by common antibiotics
Journal of Global Antimicrobial Resistance · 2026
- Rapid means of biofilm disruption induce the newly released (NRel) phenotype of enhanced antibiotic sensitivity
Frontiers in Microbiology · 2026
- Spermidine is a common component of the eDNA-dependent biofilm matrix
npj Biofilms and Microbiomes · 2026
- Respiratory tract antimicrobial peptides more effectively killed multiple methicillin-resistant <i>Staphylococcus aureus</i> and nontypeable <i>Haemophilus influenzae</i> isolates after disruption from biofilm residence
Microbiology Spectrum · 2025
- Nontypeable Haemophilus influenzae released from biofilm residence by monoclonal antibody directed against a biofilm matrix component display a vulnerable phenotype
Scientific Reports · 2023
- Z‐Form Extracellular <scp>DNA</scp> in Pediatric <scp>CRS</scp> May Provide a Mechanism for Recalcitrance to Treatment
The Laryngoscope · 2023
- High-depth RNA-Seq data sets to investigate the differences in gene expression mediated by phasevarions in non-typeable <i>Haemophilus influenzae</i>
Microbiology Resource Announcements · 2023
- Monoclonal antibodies that target extracellular DNABII proteins or the type IV pilus of nontypeable Haemophilus influenzae (NTHI) worked additively to disrupt 2-genera biofilms
Biofilm · 2022
- Australian Aboriginal Otitis-Prone Children Produce High-Quality Serum IgG to Putative Nontypeable Haemophilus influenzae Vaccine Antigens at Lower Titres Compared to Non-Aboriginal Children
Frontiers in Cellular and Infection Microbiology · 2022
- Adherence of Nontypeable Haemophilus influenzae to Cells and Substrates of the Airway Is Differentially Regulated by Individual ModA Phasevarions
Microbiology Spectrum · 2022
- Editorial: Women in biofilms 2021
Frontiers in Cellular and Infection Microbiology · 2022
- ModA phasevarions regulate adherence of non-typeable <i>Haemophilus influenzae</i> to the host airway in a tissue-specific manner
bioRxiv (Cold Spring Harbor Laboratory) · 2022
- Phase Variation in HMW1A Controls a Phenotypic Switch in Haemophilus influenzae Associated with Pathoadaptation during Persistent Infection
mBio · 2021
- Differences in Pneumococcal and Haemophilus influenzae Natural Antibody Development in Papua New Guinean Children in the First Year of Life
Frontiers in Immunology · 2021
- Targeting a bacterial DNABII protein with a chimeric peptide immunogen or humanised monoclonal antibody to prevent or treat recalcitrant biofilm-mediated infections
EBioMedicine · 2020
- The Laryngoscope×5
- Frontiers in Microbiology×5
- mBio×5
- EBioMedicine×4
- npj Biofilms and Microbiomes×4
- Kevin M. Mason
Immunology and Microbiology · The Ohio State University
- Kelly L. Weaver
Immunology and Microbiology · Indiana University
- Jesse M. Hall
Immunology and Microbiology · The Ohio State University
- Frederick W. Bauer
Immunology and Microbiology · Indiana University
- Jessica L. Gutierrez-Ferman
Immunology and Microbiology · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile